Lombardi M. Ronald's Insider Trades & SAST Disclosures
Lombardi M. Ronald's most recent trade in Acco Brands Corporation was a trade of 1,283 Restricted Stock Units done . Disclosure was reported to the exchange on Dec. 11, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Lombardi M. Ronald.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Acco Brands Corporation | Ronald M. Lombardi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Dec 2024 | 1,283 | 106,004 | - | - | Restricted Stock Units | |
| Prestige Consumer Healthca... | Ronald M. Lombardi | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 82.64 per share. | 19 Nov 2024 | 5,662 | 320,952 (0%) | 0% | 82.6 | 467,908 | Common Stock, par value $0.01 per share |
| Prestige Consumer Healthca... | Ronald M. Lombardi | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 56.11 per share. | 19 Nov 2024 | 5,662 | 326,614 (0%) | 0% | 56.1 | 317,695 | Common Stock, par value $0.01 per share |
| Prestige Consumer Healthca... | Ronald M. Lombardi | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Nov 2024 | 5,662 | 0 | - | - | Employee Stock Options (right to buy) | |
| Prestige Consumer Healthca... | Ronald M. Lombardi | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 82.55 per share. | 19 Nov 2024 | 5,213 | 320,952 (0%) | 0% | 82.5 | 430,333 | Common Stock, par value $0.01 per share |
| Prestige Consumer Healthca... | Ronald M. Lombardi | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 57.18 per share. | 19 Nov 2024 | 5,213 | 326,165 (0%) | 0% | 57.2 | 298,079 | Common Stock, par value $0.01 per share |
| Prestige Consumer Healthca... | Ronald M. Lombardi | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Nov 2024 | 5,213 | 0 | - | - | Employee Stock Options (right to buy) | |
| Prestige Consumer Healthca... | Ronald M. Lombardi | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 57.18 per share. | 18 Nov 2024 | 48,512 | 369,464 (0%) | 0% | 57.2 | 2,773,916 | Common Stock, par value $0.01 per share |
| Prestige Consumer Healthca... | Ronald M. Lombardi | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2024 | 48,512 | 5,213 | - | - | Employee Stock Options (right to buy) | |
| Prestige Consumer Healthca... | Ronald M. Lombardi | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 82.67 per share. | 18 Nov 2024 | 48,512 | 320,952 (0%) | 0% | 82.7 | 4,010,487 | Common Stock, par value $0.01 per share |
| Prestige Consumer Healthca... | Ronald M. Lombardi | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 82.41 per share. | 18 Nov 2024 | 33,725 | 320,952 (0%) | 0% | 82.4 | 2,779,277 | Common Stock, par value $0.01 per share |
| Prestige Consumer Healthca... | Ronald M. Lombardi | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2024 | 33,725 | 5,662 | - | - | Employee Stock Options (right to buy) | |
| Prestige Consumer Healthca... | Ronald M. Lombardi | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 56.11 per share. | 18 Nov 2024 | 33,725 | 354,677 (0%) | 0% | 56.1 | 1,892,310 | Common Stock, par value $0.01 per share |
| Acco Brands Corporation | Ronald M. Lombardi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Sep 2024 | 1,447 | 104,720 | - | - | Restricted Stock Units | |
| Acco Brands Corporation | Ronald M. Lombardi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 1,532 | 103,273 | - | - | Restricted Stock Units | |
| Acco Brands Corporation | Ronald M. Lombardi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 24,951 | 134,951 (0%) | 0% | 0 | Common Stock | |
| Prestige Consumer Healthca... | Ronald M. Lombardi | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 14,298 | 320,952 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Prestige Consumer Healthca... | Ronald M. Lombardi | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2024 | 85,533 | 348 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Prestige Consumer Healthca... | Ronald M. Lombardi | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 70.00 per share. | 06 May 2024 | 41,356 | 306,654 (0%) | 0% | 70 | 2,894,920 | Common Stock, par value $0.01 per share |
| Prestige Consumer Healthca... | Ronald M. Lombardi | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 70.00 per share. | 02 May 2024 | 3,000 | 262,477 (0%) | 0% | 70 | 210,000 | Common Stock, par value $0.01 per share |
| Prestige Consumer Healthca... | Ronald M. Lombardi | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.26 per share. | 02 May 2024 | 2,664 | 267,893 (0%) | 0% | 71.3 | 189,837 | Common Stock, par value $0.01 per share |
| Prestige Consumer Healthca... | Ronald M. Lombardi | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.26 per share. | 02 May 2024 | 2,416 | 265,477 (0%) | 0% | 71.3 | 172,164 | Common Stock, par value $0.01 per share |
| Acco Brands Corporation | Ronald M. Lombardi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2024 | 1,344 | 101,740 | - | - | Restricted Stock Units | |
| Acco Brands Corporation | Lombardi M. Ronald | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Dec 2023 | 1,375 | 100,396 | - | - | Restricted Stock Units | |
| Acco Brands Corporation | Ronald M. Lombardi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2023 | 1,369 | 99,020 | - | - | Restricted Stock Units | |
| Prestige Consumer Healthca... | Ronald M. Lombardi | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 33.50 per share. | 08 Aug 2023 | 32,800 | 303,357 (0%) | 0% | 33.5 | 1,098,800 | Common Stock, par value $0.01 per share |
| Prestige Consumer Healthca... | Ronald M. Lombardi | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Aug 2023 | 32,800 | 0 | - | - | Employee Stock Options (right to buy) | |
| Prestige Consumer Healthca... | Ronald M. Lombardi | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 64.97 per share. | 08 Aug 2023 | 22,249 | 281,108 (0%) | 0% | 65.0 | 1,445,518 | Common Stock, par value $0.01 per share |
| Prestige Consumer Healthca... | Ronald M. Lombardi | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 66.99 per share. | 08 Aug 2023 | 5,052 | 272,448 (0%) | 0% | 67.0 | 338,433 | Common Stock, par value $0.01 per share |
| Prestige Consumer Healthca... | Ronald M. Lombardi | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 65.99 per share. | 08 Aug 2023 | 3,608 | 277,500 (0%) | 0% | 66.0 | 238,092 | Common Stock, par value $0.01 per share |
| Prestige Consumer Healthca... | Ronald M. Lombardi | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 67.95 per share. | 08 Aug 2023 | 1,891 | 270,557 (0%) | 0% | 67.9 | 128,493 | Common Stock, par value $0.01 per share |
| Acco Brands Corporation | Ronald M. Lombardi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 1,401 | 97,651 | - | - | Restricted Stock Units | |
| Acco Brands Corporation | Ronald M. Lombardi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2023 | 23,855 | 96,250 | - | - | Restricted Stock Units | |
| Prestige Consumer Healthca... | Ronald M. Lombardi | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2023 | 87,854 | 318,680 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Prestige Consumer Healthca... | Ronald M. Lombardi | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 62.02 per share. | 04 May 2023 | 44,850 | 273,830 (0%) | 0% | 62.0 | 2,781,597 | Common Stock, par value $0.01 per share |
| Prestige Consumer Healthca... | Ronald M. Lombardi | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 62.02 per share. | 04 May 2023 | 3,273 | 270,557 (0%) | 0% | 62.0 | 202,991 | Common Stock, par value $0.01 per share |
| Prestige Consumer Healthca... | Ronald M. Lombardi | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 61.25 per share. | 03 May 2023 | 3,167 | 230,826 (0%) | 0% | 61.3 | 193,979 | Common Stock, par value $0.01 per share |
| Prestige Consumer Healthca... | Ronald M. Lombardi | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2023 | 14,985 | 233,993 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Prestige Consumer Healthca... | Ronald M. Lombardi | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 61.73 per share. | 02 May 2023 | 2,812 | 219,008 (0%) | 0% | 61.7 | 173,585 | Common Stock, par value $0.01 per share |
| Acco Brands Corporation | Ronald M. Lombardi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Apr 2023 | 1,057 | 72,395 | - | - | Restricted Stock Units | |
| Acco Brands Corporation | Ronald M. Lombardi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2022 | 941 | 71,337 | - | - | Restricted Stock Units | |
| Prestige Consumer Healthca... | Ronald M. Lombardi | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.94 per share. | 18 Nov 2022 | 38,793 | 260,613 (0%) | 0% | 29.9 | 1,161,462 | Common Stock, par value $0.01 per share |
| Prestige Consumer Healthca... | Ronald M. Lombardi | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2022 | 38,793 | 0 | - | - | Employee Stock Options (right to buy) | |
| Prestige Consumer Healthca... | Ronald M. Lombardi | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 59.10 per share. | 18 Nov 2022 | 38,793 | 221,820 (0%) | 0% | 59.1 | 2,292,569 | Common Stock, par value $0.01 per share |
| Acco Brands Corporation | Ronald M. Lombardi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Sep 2022 | 953 | 70,396 | - | - | Restricted Stock Units | |
| Acco Brands Corporation | Ronald M. Lombardi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 759 | 69,442 | - | - | Restricted Stock Units | |
| Acco Brands Corporation | Ronald M. Lombardi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2022 | 16,579 | 68,683 | - | - | Restricted Stock Units | |
| Prestige Consumer Healthca... | Ronald M. Lombardi | Chief Executive Office | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2022 | 107,916 | 278,053 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Prestige Consumer Healthca... | Ronald M. Lombardi | Chief Executive Office | Payment of exercise price or tax liability using portion of securities received from the company at price $ 54.88 per share. | 06 May 2022 | 52,178 | 225,875 (0%) | 0% | 54.9 | 2,863,529 | Common Stock, par value $0.01 per share |
| Prestige Consumer Healthca... | Ronald M. Lombardi | Chief Executive Office | Payment of exercise price or tax liability using portion of securities received from the company at price $ 54.88 per share. | 06 May 2022 | 4,055 | 221,820 (0%) | 0% | 54.9 | 222,538 | Common Stock, par value $0.01 per share |
| Prestige Consumer Healthca... | Ronald M. Lombardi | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 55.34 per share. | 04 May 2022 | 3,099 | 170,137 (0%) | 0% | 55.3 | 171,499 | Common Stock, par value $0.01 per share |
| Prestige Consumer Healthca... | Ronald M. Lombardi | Chief Executive Office | Payment of exercise price or tax liability using portion of securities received from the company at price $ 54.44 per share. | 03 May 2022 | 3,000 | 173,236 (0%) | 0% | 54.4 | 163,320 | Common Stock, par value $0.01 per share |
| Prestige Consumer Healthca... | Ronald M. Lombardi | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2022 | 16,523 | 176,236 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Acco Brands Corporation | Ronald M. Lombardi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2022 | 466 | 52,104 | - | - | Restricted Stock Units | |
| Acco Brands Corporation | Ronald M. Lombardi | Director | Purchase of securities on an exchange or from another person at price $ 8.85 per share. | 17 Feb 2022 | 60,000 | 110,000 (0%) | 0% | 8.9 | 531,072 | Common Stock |
| Acco Brands Corporation | Ronald M. Lombardi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2021 | 477 | 51,637 | - | - | Restricted Stock Units | |
| Prestige Consumer Healthca... | Ronald M. Lombardi | Chief Executive Office | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2021 | 52,367 | 0 | - | - | Employee Stock Option (right to buy) | |
| Prestige Consumer Healthca... | Ronald M. Lombardi | Chief Executive Office | Sale of securities on an exchange or to another person at price $ 62.78 per share. | 12 Nov 2021 | 52,367 | 159,713 (0%) | 0% | 62.8 | 3,287,600 | Common Stock, par value $0.01 per share |
| Prestige Consumer Healthca... | Ronald M. Lombardi | Chief Executive Office | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.24 per share. | 12 Nov 2021 | 52,367 | 212,080 (0%) | 0% | 13.2 | 693,339 | Common Stock, par value $0.01 per share |
| Acco Brands Corporation | Ronald M. Lombardi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2021 | 369 | 51,160 | - | - | Restricted Stock Units | |
| Acco Brands Corporation | Ronald M. Lombardi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2021 | 385 | 50,791 | - | - | Restricted Stock Units | |
| Acco Brands Corporation | Ronald M. Lombardi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 11,881 | 50,405 | - | - | Restricted Stock Units | |
| Prestige Consumer Healthca... | Ronald M. Lombardi | Chief Executive Office | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2021 | 27,281 | 186,994 (0%) | 0% | 0 | Common Stock | |
| Prestige Consumer Healthca... | Ronald M. Lombardi | Chief Executive Office | Payment of exercise price or tax liability using portion of securities received from the company at price $ 46.10 per share. | 07 May 2021 | 25,540 | 157,601 (0%) | 0% | 46.1 | 1,177,394 | Common Stock |
| Prestige Consumer Healthca... | Ronald M. Lombardi | Chief Executive Office | Payment of exercise price or tax liability using portion of securities received from the company at price $ 46.10 per share. | 07 May 2021 | 3,853 | 183,141 (0%) | 0% | 46.1 | 177,623 | Common Stock |
| Prestige Consumer Healthca... | Ronald M. Lombardi | Chief Executive Office | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.10 per share. | 06 May 2021 | 4,055 | 159,713 (0%) | 0% | 47.1 | 190,991 | Common Stock, par value $0.01 per share |
| Prestige Consumer Healthca... | Ronald M. Lombardi | Chief Executive Office | Payment of exercise price or tax liability using portion of securities received from the company at price $ 44.32 per share. | 04 May 2021 | 3,099 | 163,768 (0%) | 0% | 44.3 | 137,348 | Common Stock, par value $0.01 per share |
| Prestige Consumer Healthca... | Ronald M. Lombardi | Chief Executive Office | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2021 | 18,610 | 166,867 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Acco Brands Corporation | Ronald M. Lombardi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2021 | 297 | 38,524 | - | - | Restricted Stock Units | |
| Acco Brands Corporation | Ronald M. Lombardi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Dec 2020 | 278 | 38,227 | - | - | Restricted Stock Units | |
| Acco Brands Corporation | Ronald M. Lombardi | Director | Purchase of securities on an exchange or from another person at price $ 6.83 per share. | 13 Nov 2020 | 50,000 | 50,000 (0%) | 0% | 6.8 | 341,745 | Common Stock |
| Acco Brands Corporation | Ronald M. Lombardi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Sep 2020 | 392 | 37,948 | - | - | Restricted Stock Units | |
| Acco Brands Corporation | Ronald M. Lombardi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2020 | 365 | 37,556 | - | - | Restricted Stock Units | |
| Acco Brands Corporation | Ronald M. Lombardi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2020 | 12,666 | 37,190 | - | - | Restricted Stock Units | |
| Prestige Consumer Healthca... | Ronald M. Lombardi | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 40.00 per share. | 12 May 2020 | 29,593 | 148,257 (0%) | 0% | 40 | 1,183,720 | Common Stock |
| Prestige Consumer Healthca... | Ronald M. Lombardi | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 May 2020 | 23,220 | 0 | - | - | Employee Stock Option (right to buy) | |
| Prestige Consumer Healthca... | Ronald M. Lombardi | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.27 per share. | 12 May 2020 | 23,220 | 177,850 (0%) | 0% | 11.3 | 261,689 | Common Stock |
| Prestige Consumer Healthca... | Ronald M. Lombardi | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 May 2020 | 6,373 | 0 | - | - | Employee Stock Option (right to buy) | |
| Prestige Consumer Healthca... | Ronald M. Lombardi | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.90 per share. | 12 May 2020 | 6,373 | 154,630 (0%) | 0% | 11.9 | 75,839 | Common Stock |
| Prestige Consumer Healthca... | Ronald M. Lombardi | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 56.11 per share. | 08 May 2020 | 5,933 | 148,257 (0%) | 0% | 56.1 | 332,901 | Common Stock |
| Prestige Consumer Healthca... | Ronald M. Lombardi | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 56.11 per share. | 08 May 2020 | 2,441 | 154,190 (0%) | 0% | 56.1 | 136,965 | Common Stock |
| Prestige Consumer Healthca... | Ronald M. Lombardi | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.56 per share. | 06 May 2020 | 4,054 | 160,268 (0%) | 0% | 30.6 | 123,890 | Common Stock |
| Prestige Consumer Healthca... | Ronald M. Lombardi | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.46 per share. | 06 May 2020 | 3,637 | 156,631 (0%) | 0% | 29.5 | 107,146 | Common Stock |
| Prestige Consumer Healthca... | Ronald M. Lombardi | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2020 | 19,228 | 164,322 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Acco Brands Corporation | Ronald M. Lombardi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Mar 2020 | 326 | 24,524 | - | - | Restricted Stock Units |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges